A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug
Authors:
- Arvind K. BansalABArvind K. Bansal
- 1 September 2007
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 32 (1) , 45-57
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Drugs as materials: valuing physical form in drug discoveryNature Reviews Drug Discovery, 2004
- Stability and Solubility of Celecoxib-PVP Amorphous Dispersions: A Molecular PerspectivePharmaceutical Research, 2004
- Physical Stability and Solubility Advantage from Amorphous Celecoxib: The Role of Thermodynamic Quantities and Molecular MobilityMolecular Pharmaceutics, 2004
- Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by liquid chromatographyJournal of Chromatography B, 2003
- Disordered drug delivery: destiny, dynamics and the Deborah numberJournal of Pharmacy and Pharmacology, 2002
- Molecular mobility study of amorphous and crystalline phases of a pharmaceutical product by thermally stimulated current spectrometryJournal of Pharmaceutical Sciences, 2002
- The use of thermal methods for predicting glass-former fragilityThermochimica Acta, 2001
- Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II DrugsPharmaceutical Research, 1998
- The old problems of glass and the glass transition, and the many new twists.Proceedings of the National Academy of Sciences, 1995
- Increased metastable solubility of milled griseofulvin, depending on the formation of a disordered surface structureInternational Journal of Pharmaceutics, 1994